Ribavirin Injection

Ribavirin Injection is used in combination with interferon or direct-acting antivirals (DAAs) to treat chronic hepatitis C virus (HCV) infection. It helps reduce the viral load and improve liver function, leading to sustained virological response (SVR) in many patients.

Ribavirin is used to treat severe RSV infections in hospitalized infants and young children, particularly those at high risk of complications. It helps reduce the severity of symptoms and the duration of the infection.

It is used as part of the treatment regimen for certain viral hemorrhagic fevers, such as Lassa fever, Marburg virus, and Crimean-Congo hemorrhagic fever (CCHF), where it may help reduce viral replication and improve patient outcomes.

In some cases, Ribavirin Injection is used in patients with chronic respiratory infections caused by viruses, particularly when other antiviral treatments are ineffective or not tolerated.

Ribavirin may be used as a prophylactic treatment for viral infections in patients who have undergone organ transplants, especially to prevent the development of infections caused by RNA viruses.

It has been used off-label in some cases for the treatment of Hantavirus pulmonary syndrome (HPS), where it helps reduce viral replication and improve survival rates in patients.